These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30794561)

  • 1. Age targeting and scale-up of voluntary medical male circumcision in Mozambique.
    Dent J; Gaspar N; Njeuhmeli E; Kripke K
    PLoS One; 2019; 14(2):e0211958. PubMed ID: 30794561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Economic and Epidemiological Impact of Focusing Voluntary Medical Male Circumcision for HIV Prevention on Specific Age Groups and Regions in Tanzania.
    Kripke K; Perales N; Lija J; Fimbo B; Mlanga E; Mahler H; Juma JM; Baingana E; Plotkin M; Kakiziba D; Semini I; Castor D; Njeuhmeli E
    PLoS One; 2016; 11(7):e0153363. PubMed ID: 27410384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Progress, Impact, and Next Steps in Rolling Out Voluntary Medical Male Circumcision for HIV Prevention in 14 Priority Countries in Eastern and Southern Africa through 2014.
    Kripke K; Njeuhmeli E; Samuelson J; Schnure M; Dalal S; Farley T; Hankins C; Thomas AG; Reed J; Stegman P; Bock N
    PLoS One; 2016; 11(7):e0158767. PubMed ID: 27441648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces.
    Kripke K; Chen PA; Vazzano A; Thambinayagam A; Pillay Y; Loykissoonlal D; Bonnecwe C; Barron P; Kiwango E; Castor D; Njeuhmeli E
    PLoS One; 2016; 11(7):e0157071. PubMed ID: 27409079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0.
    Kripke K; Opuni M; Schnure M; Sgaier S; Castor D; Reed J; Njeuhmeli E; Stover J
    PLoS One; 2016; 11(7):e0156909. PubMed ID: 27410966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voluntary Medical Male Circumcision for HIV Prevention in Swaziland: Modeling the Impact of Age Targeting.
    Kripke K; Okello V; Maziya V; Benzerga W; Mirira M; Gold E; Schnure M; Sgaier S; Castor D; Reed J; Njeuhmeli E
    PLoS One; 2016; 11(7):e0156776. PubMed ID: 27410687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography.
    Kripke K; Chimbwandira F; Mwandi Z; Matchere F; Schnure M; Reed J; Castor D; Sgaier S; Njeuhmeli E
    PLoS One; 2016; 11(7):e0156521. PubMed ID: 27410474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa.
    Njeuhmeli E; Forsythe S; Reed J; Opuni M; Bollinger L; Heard N; Castor D; Stover J; Farley T; Menon V; Hankins C
    PLoS Med; 2011 Nov; 8(11):e1001132. PubMed ID: 22140367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data triangulation to estimate age-specific coverage of voluntary medical male circumcision for HIV prevention in four Kenyan counties.
    Kripke K; Opuni M; Odoyo-June E; Onyango M; Young P; Serrem K; Ojiambo V; Schnure M; Stegman P; Njeuhmeli E
    PLoS One; 2018; 13(12):e0209385. PubMed ID: 30562394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the Impact of Uganda's Safe Male Circumcision Program: Implications for Age and Regional Targeting.
    Kripke K; Vazzano A; Kirungi W; Musinguzi J; Opio A; Ssempebwa R; Nakawunde S; Kyobutungi S; Akao JN; Magala F; Mwidu G; Castor D; Njeuhmeli E
    PLoS One; 2016; 11(7):e0158693. PubMed ID: 27410234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Impact and Cost-Effectiveness of Increased Efforts to Attract Voluntary Medical Male Circumcision Clients Ages 20-29 in Zimbabwe.
    Kripke K; Hatzold K; Mugurungi O; Ncube G; Xaba S; Gold E; Ahanda KS; Kruse-Levy N; Njeuhmeli E
    PLoS One; 2016; 11(10):e0164144. PubMed ID: 27783637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voluntary Medical Male Circumcision to Prevent HIV: Modelling Age Prioritization in Namibia.
    Stegman P; Stirling B; Corner B; Schnure M; Mali D; Shihepo E; Kripke K; Njeuhmeli E
    AIDS Behav; 2019 Sep; 23(Suppl 2):195-205. PubMed ID: 31214866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaling Up Voluntary Medical Male Circumcision for Human Immunodeficiency Virus Prevention for Adolescents and Young Adult Men: A Modeling Analysis of Implementation and Impact in Selected Countries.
    Njeuhmeli E; Opuni M; Schnure M; Tchuenche M; Stegman P; Gold E; Kiggundu V; Parks N; Seifert Ahanda K; Carrasco M; Kripke K
    Clin Infect Dis; 2018 Apr; 66(suppl_3):S166-S172. PubMed ID: 29617778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography.
    Hankins C; Warren M; Njeuhmeli E
    PLoS One; 2016; 11(10):e0160699. PubMed ID: 27783613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
    Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
    PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating Voluntary Medical Male Circumcision Program Efficiency Gains through Subpopulation Prioritization: Insights from Application to Zambia.
    Awad SF; Sgaier SK; Tambatamba BC; Mohamoud YA; Lau FK; Reed JB; Njeuhmeli E; Abu-Raddad LJ
    PLoS One; 2015; 10(12):e0145729. PubMed ID: 26716442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using mathematical modeling to inform health policy: A case study from voluntary medical male circumcision scale-up in eastern and southern Africa and proposed framework for success.
    Njeuhmeli E; Schnure M; Vazzano A; Gold E; Stegman P; Kripke K; Tchuenche M; Bollinger L; Forsythe S; Hankins C
    PLoS One; 2019; 14(3):e0213605. PubMed ID: 30883583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Costs and Impacts of Introducing Early Infant Male Circumcision for Long-Term Sustainability of the Voluntary Medical Male Circumcision Program.
    Njeuhmeli E; Stegman P; Kripke K; Mugurungi O; Ncube G; Xaba S; Hatzold K; Christensen A; Stover J
    PLoS One; 2016; 11(7):e0159167. PubMed ID: 27410233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis.
    Haacker M; Fraser-Hurt N; Gorgens M
    PLoS Med; 2016 May; 13(5):e1002012. PubMed ID: 27138961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and impacts of scaling up voluntary medical male circumcision in Tanzania.
    Menon V; Gold E; Godbole R; Castor D; Mahler H; Forsythe S; Ally M; Njeuhmeli E
    PLoS One; 2014; 9(5):e83925. PubMed ID: 24802022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.